Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001137774-25-000078·Arcutis Biotherapeutics, Inc.
Schedule 13G ownership disclosure
Arcutis Biotherapeutics Inc
Common · CUSIP: 03969K108
Event date: 2025-03-31
- Filing-level shares
- 11,954,070.00
- Percent of class
- 10.1%
- PRUDENTIAL FINANCIAL INC
Shares: 11,954,070.00 · Class: 10.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001137774-25-000078
- Form type
- SCHEDULE 13G/A
- Filer
- Arcutis Biotherapeutics, Inc.
- CIK
- CIK 1787306
- Filed
- May 15, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership